CD8A and neoplasm: CXCL9/10/11 are ligands for CXC-chemokine receptor 3 (CXCR3), which is highly expressed on cytotoxic CD8+ T cells and IFN-γ-producing CD4+ T helper 1 cells, both of which provoke tumor cell killing and enhance inflammation in the TME.